Ferring launched MINIRIN®, an anti-diuretic hormone used initially to treat diabetes insipidus and later primary nocturnal enuresis, or bedwetting. MINIRIN soon became the most important product in Ferring’s product portfolio.
Launch of MINIRIN
UNCATEGORIZED > Launch of MINIRIN